Rivaroxaban, long known under the brand name Xarelto, is an anticoagulant, a classification that is among the most-prescribed medications in the United States.

Magnified View of Lipid Nanoparticles | Image Credit: ©Aniwat - stock.adobe.com

Organic Nanoparticle-Based Drug-Delivery Systems as Alternatives to Lipid Nanoparticles

By Cynthia A. Challener

March 9th 2025

Exosomes, polymeric nanoparticles, and DNA nanostructures offer many potential advantages.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Approves Evrysdi Tablet from Roche for Spinal Muscular Atrophy

By Feliza Mirasol

February 17th 2025

The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.

Two dosing pens of a fictitious semaglutide drug (GLP-1) on a scale facing a dumbbell. Concept for alternative ways to loose weight. | Image Credit: © Andreas Prott - Stock.adobe.com

Next-Generation Anti-Obesity Medicines

By Cheryl Barton

February 8th 2025

European biopharma companies are looking beyond GLP-1s.

Hand of young man with pill, closeup. Image Credit: ©Africa Studio - stock.adobe.com

Evolving Approaches to Taste Masking

By Cynthia A. Challener

February 7th 2025

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.

...

131 132 133 134 135

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777